跳至主要内容
临床试验/NCT03941886
NCT03941886已完成不适用

Implementation of First-trimester Screening and Prevention of Preeclampsia: a Stepped Wedge Cluster-randomized Trial in Asia

Chiu Yee Liona Poon20 个研究点 分布在 10 个国家目标入组 42,454 人开始时间: 2019年7月31日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
42,454
试验地点
20
主要终点
Delivery with preterm-preeclampsia

研究概览

简要总结

This implementation study aims to evaluate the efficacy, acceptability, and safety of first-trimester screening and prevention for preterm-preeclampsia. It is a multicenter stepped wedge cluster randomized trial including maternity / diagnostic units from ten regions in Asia. The study involves a period where no intervention will take place at all recruiting units, and then at regular intervals, one cluster will be randomized to transit from non-intervention group to intervention group in which first-trimester screening for preterm-preeclampsia by the Bayes based method followed by the commencement of low-dose aspirin in high-risk women.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Sequential
主要目的
Prevention
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Singleton pregnancy;
  • Live fetus;

排除标准

  • Multiple pregnancy;
  • Major fetal defects identified at 11-13 weeks of assessment;
  • Non-viable fetus (missed spontaneous abortion or stillbirth).

结局指标

主要结局

Delivery with preterm-preeclampsia

时间窗: Before 37 weeks of gestation

Proportions of delivery with preterm preeclampsia between non-intervention and intervention groups

次要结局

  • Low birth weight(at birth)
  • Spontaneous preterm birth(At <34 and <37 weeks' gestation)
  • Adverse outcomes with delivery at <34, <37 and ≥37 weeks of gestation(at <34, <37 and ≥37 weeks of gestation)
  • Gestational age at delivery(at delivery)
  • Composite neonatal therapy(during the first 28 days of life (0-27 days))
  • Neonatal mortality(during the first 28 days of life (0-27 days))
  • Stillbirth(at or after 20 to 28 weeks of pregnancy)
  • Acceptability for PE screening(in the first trimester of pregnancy (11-13 weeks of gestation))
  • Acceptability for aspirin treatment.(from <15 weeks till 36 weeks of gestation or, in the event of early delivery, at the onset of labor)
  • Composite neonatal morbidity(during the first 28 days of life (0-27 days))

研究者

发起方
Chiu Yee Liona Poon
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Chiu Yee Liona Poon

Professor (Clinical)

Chinese University of Hong Kong

研究点 (20)

Loading locations...

相似试验